About DNA-directed DNA/RNA polymerase mu
DNA-directed DNA/RNA polymerase mu (POLM) is a protein
from Homo sapiens identified by UniProt accession
Q9NP87, 494 residues long.
MolForge cross-references it against 0 known binders and
79 disease associations.
Target properties
| Protein name | DNA-directed DNA/RNA polymerase mu |
| UniProt accession | Q9NP87 |
| Gene | POLM |
| Organism | Homo sapiens |
| Length | 494 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (79)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.31
- breast adenocarcinoma · score 0.23
- ovarian cancer · score 0.18
- lung adenocarcinoma · score 0.12
- mean platelet volume · score 0.10
- clear cell renal carcinoma · score 0.10
- esophageal cancer · score 0.09
- reticulocyte count · score 0.09
- neutropenia, severe congenital, 2, autosomal dominant · score 0.07
- Okt4 epitope deficiency · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NP87-F1 | alphafold | PREDICTED | 88.56 | — |
Amino-acid sequence (494 residues)
MLPKRRRARV GSPSGDAASS TPPSTRFPGV AIYLVEPRMG RSRRAFLTGL ARSKGFRVLD ACSSEATHVV MEETSAEEAV SWQERRMAAA PPGCTPPALL DISWLTESLG AGQPVPVECR HRLEVAGPRK GPLSPAWMPA YACQRPTPLT HHNTGLSEAL EILAEAAGFE GSEGRLLTFC RAASVLKALP SPVTTLSQLQ GLPHFGEHSS RVVQELLEHG VCEEVERVRR SERYQTMKLF TQIFGVGVKT ADRWYREGLR TLDDLREQPQ KLTQQQKAGL QHHQDLSTPV LRSDVDALQQ VVEEAVGQAL PGATVTLTGG FRRGKLQGHD VDFLITHPKE GQEAGLLPRV MCRLQDQGLI LYHQHQHSCC ESPTRLAQQS HMDAFERSFC IFRLPQPPGA AVGGSTRPCP SWKAVRVDLV VAPVSQFPFA LLGWTGSKLF QRELRRFSRK EKGLWLNSHG LFDPEQKTFF QAASEEDIFR HLGLEYLPPE QRNA
Explore DNA-directed DNA/RNA polymerase mu with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets